Abstract
The cruzain, major cysteine protease of Trypanosoma cruzi, is an essential enzyme for the parasite's life cycle and it has been used as a viable target for searching new enzyme inhibitors candidate as pharmaceutical drugs. The peptide-mimetic compound K777 inhibits cruzain at nanomolar concentrations, and acts by irreversible inhibition mechanism. Analogues or derivatives of K777 generall…